全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

NLRP3炎症小体在抑郁症发病机制中的作用及中药干预的研究
The Role of NLRP3 Inflammasome in the Pathogenesis of Depression and the Intervention of Traditional Chinese Medicine

DOI: 10.12677/tcm.2025.141009, PP. 58-66

Keywords: 抑郁症,NLRP3炎症小体,中药,神经递质,HPA轴
Depression
, NLRP3 Inflammasome, Traditional Chinese Medicine, Neurotransmitter, HPA Axis

Full-Text   Cite this paper   Add to My Lib

Abstract:

抑郁症的发病机制与炎症小体,特别是NLRP3炎症小体的激活密切相关,炎症反应在抑郁症的发生和发展中发挥着关键作用。中药通过抑制NLRP3炎症小体的活性及其相关促炎因子的表达,显示出显著的抗抑郁效果,且其机制涉及神经递质的调节、神经营养因子的提升以及HPA轴的调控。未来的研究应进一步探讨中药对炎症小体的具体调控机制,并推动其在临床应用中的个体化治疗策略,以期为抑郁症的防治提供新的思路。
The pathogenesis of depression is closely related to the inflammasome, particularly the activation of the NLRP3 inflammasome. Inflammatory responses play a critical role in the onset and progression of depression. Traditional Chinese medicine has demonstrated significant antidepressant effects by inhibiting the activity of the NLRP3 inflammasome and the expression of its related pro-inflammatory factors. The mechanisms involved include the regulation of neurotransmitters, the enhancement of neurotrophic factors, and the modulation of the HPA axis. Future research should further investigate the specific regulatory mechanisms of traditional Chinese medicine on the inflammasome and promote individualized treatment strategies in clinical applications, with the aim of providing new perspectives for the prevention and treatment of depression.

References

[1]  张楠, 许二平, 陈玉龙. NLRP3炎症小体与抑郁症的关系及中医药的干预作用[J]. 中国实验方剂学杂志, 2023, 29(3): 186-193.
[2]  Akcay, E. and Karatas, H. (2024) P2X7 Receptors from the Perspective of NLRP3 Inflammasome Pathway in Depression: Potential Role of Cannabidiol. Brain, Behavior, & ImmunityHealth, 41, Article ID: 100853.
https://doi.org/10.1016/j.bbih.2024.100853

[3]  Han, Q., Li, W., Chen, P., Wang, L., Bao, X., Huang, R., et al. (2023) Microglial NLRP3 Inflammasome-Mediated Neuroinflammation and Therapeutic Strategies in Depression. Neural Regeneration Research, 19, 1890-1898.
https://doi.org/10.4103/1673-5374.390964

[4]  Wu, D., Zhong, P., Wang, J. and Wang, H. (2019) Exogenous Hydrogen Sulfide Mitigates LPS + ATP-Induced Inflammation by Inhibiting NLRP3 Inflammasome Activation and Promoting Autophagy in L02 Cells. Molecular and Cellular Biochemistry, 457, 145-156.
https://doi.org/10.1007/s11010-019-03519-6

[5]  Henedak, N.T., El-Abhar, H.S., Abdallah, D.M., Ahmed, K.A. and Soubh, A.A. (2024) Demotion of Canonical/Non-Canonical Inflammasome and Pyroptosis Alleviates Ischemia/Reperfusion-Induced Acute Kidney Injury: Novel Role of the D2/D3 Receptor Agonist Ropinirole. European Journal of Pharmacology, 969, Article ID: 176460.
https://doi.org/10.1016/j.ejphar.2024.176460

[6]  Su, L., Lu, H., Zhang, D., Zhu, X., Li, J., Zong, Y., et al. (2024) Total Paeony Glycoside Relieves Neuroinflammation to Exert Antidepressant Effect via the Interplay between NLRP3 Inflammasome, Pyroptosis and Autophagy. Phytomedicine, 128, Article ID: 155519.
https://doi.org/10.1016/j.phymed.2024.155519

[7]  刘永芳, 周莉, 刘晖扬, 黄睿, 丰志滢, 尹甜甜. NLRP3炎症小体在IgA肾病中的作用及中药干预进展[J]. 中国实验方剂学杂志, 2024, 30(6): 269-279.
[8]  李向洲, 邢涛, 钱朝良, 韩李霞, 杨博. NLRP3炎症小体在骨关节疾病中的作用及中医药干预进展[J]. 中国实验方剂学杂志, 2023, 29(18): 241-250.
[9]  赵哲, 白敏, 靳玉秋, 田萌媛, 陈光顺, 刘臻华. 中医药调控NLRP3炎症小体治疗糖尿病肾病的研究进展[J]. 中国实验方剂学杂志, 2023, 29(23): 197-206.
[10]  Nampoothiri, M., Gurram, P.C., Manandhar, S., Satarker, S., Mudgal, J. and Arora, D. (2023) Dopaminergic Signaling as a Plausible Modulator of Astrocytic Toll-Like Receptor 4: A Crosstalk between Neuroinflammation and Cognition. CNS & Neurological DisordersDrug Targets, 22, 539-557.
https://doi.org/10.2174/1871527321666220413090541

[11]  Chanchal, S., Mishra, A., Singh, M.K. and Ashraf, M.Z. (2020) Understanding Inflammatory Responses in the Manifestation of Prothrombotic Phenotypes. Frontiers in Cell and Developmental Biology, 8, Article 73.
https://doi.org/10.3389/fcell.2020.00073

[12]  Kelley, N., Jeltema, D., Duan, Y. and He, Y. (2019) The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. International Journal of Molecular Sciences, 20, Article 3328.
https://doi.org/10.3390/ijms20133328

[13]  Sharma, B.R. and Kanneganti, T. (2021) NLRP3 Inflammasome in Cancer and Metabolic Diseases. Nature Immunology, 22, 550-559.
https://doi.org/10.1038/s41590-021-00886-5

[14]  Wang, M., Yan, S., Zhou, Y. and Xie, P. (2020) Trans‐Cinnamaldehyde Reverses Depressive‐Like Behaviors in Chronic Unpredictable Mild Stress Rats by Inhibiting NF‐κB/NLRP3 Inflammasome Pathway. Evidence-Based Complementary and Alternative Medicine, 2020, Article ID: 4572185.
https://doi.org/10.1155/2020/4572185

[15]  Tufekci, K.U., Ercan, I., Isci, K.B., Olcum, M., Tastan, B., Gonul, C.P., et al. (2021) Sulforaphane Inhibits NLRP3 Inflammasome Activation in Microglia through NRF2-Mediated Mirna Alteration. Immunology Letters, 233, 20-30.
https://doi.org/10.1016/j.imlet.2021.03.004

[16]  丁杨, 胡容. NLRP3炎症小体激活及调节机制的研究进展[J]. 药学进展, 2018, 42(4): 294-302.
[17]  李明襄, 张立娟, 韩欢, 毕淑月, 王康锋. 中医药调控NLRP3炎症小体治疗阿尔茨海默病研究现状[J]. 山东中医药大学学报, 2023, 47(4): 508-513.
[18]  王颖逸, 刘青松, 张怡, 陈双兰, 孙旭辉, 田怀娥, 袁玲玲. 基于NLRP3炎性小体探讨中医药治疗溃疡性结肠炎的研究进展[J]. 中国实验方剂学杂志, 2023, 29(15): 232-241.
[19]  卡玉秀, 刘维, 丁久力, 林芳芳, 陈婌娟, 顾庆香, 岳青云, 樊一桦. 生物碱类天然药物抗痛风作用及作用机制的研究进展[J]. 天津中医药, 2023, 40(12): 1621-1626.
[20]  华荣, 陈瑶. 益母草碱抑制NLRP3炎症小体过度激活调控巨噬细胞M1/M2表型分化[J]. 药学实践杂志, 2021, 39(2): 143-147.
[21]  王春霞, 葛俊李, 李芳, 赵鲲鹏, 邵士俊, 杨扶德, 冯金梁. 中药治疗溃疡性结肠炎作用及机制研究进展[J]. 中国实验方剂学杂志, 2023, 29(2): 270-282.
[22]  Jia, K., Ding, H., Yu, H., Dong, T., Pan, Y. and Kong, L. (2018) Huanglian-Wendan Decoction Inhibits NF-κB/NLRP3 Inflammasome Activation in Liver and Brain of Rats Exposed to Chronic Unpredictable Mild Stress. Mediators of Inflammation, 2018, Article ID: 3093516.
https://doi.org/10.1155/2018/3093516

[23]  Jia, K., Pan, S., Ding, H., Liu, J., Zheng, Y., Wang, S., et al. (2018) Chaihu-Shugan San Inhibits Inflammatory Response to Improve Insulin Signaling in Liver and Prefrontal Cortex of CUMS Rats with Glucose Intolerance. Biomedicine & Pharmacotherapy, 103, 1415-1428.
https://doi.org/10.1016/j.biopha.2018.04.171

[24]  Hao, W., Wu, J., Yuan, N., Gong, L., Huang, J., Ma, Q., et al. (2021) Xiaoyaosan Improves Antibiotic-Induced Depressive-Like and Anxiety-Like Behavior in Mice through Modulating the Gut Microbiota and Regulating the NLRP3 Inflammasome in the Colon. Frontiers in Pharmacology, 12, Article 619103.
https://doi.org/10.3389/fphar.2021.619103

[25]  Jing, W., Song, S., Sun, H., Chen, Y., Zhao, Q., Zhang, Y., et al. (2019) Mahuang-Fuzi-Xixin Decoction Reverses Depression-Like Behavior in LPS-Induced Mice by Regulating NLRP3 Inflammasome and Neurogenesis. Neural Plasticity, 2019, Article ID: 1571392.
https://doi.org/10.1155/2019/1571392

[26]  Zhang, W., Guo, Y., Han, W., Yang, M., Wen, L., Wang, K., et al. (2019) Curcumin Relieves Depressive-Like Behaviors via Inhibition of the NLRP3 Inflammasome and Kynurenine Pathway in Rats Suffering from Chronic Unpredictable Mild Stress. International Immunopharmacology, 67, 138-144.
https://doi.org/10.1016/j.intimp.2018.12.012

[27]  Wang, T. (2010) Effects of Chinese Herbal Medicine Xiaoyao Powder on Monoamine Neurotransmitters in Hippocampus of Rats with Postpartum Depression. Journal of Chinese Integrative Medicine, 8, 1075-1079.
https://doi.org/10.3736/jcim20101112

[28]  刘传勇, 陈广烈, 张丽娜, 等. 补中益气汤联合西药治疗心脾两虚型抑郁症疲劳感临床研究[J]. 新中医, 2022, 54(13): 1-5.
[29]  吴慧萍. 柴胡疏肝散联合逍遥散治疗产后抑郁症疗效临床研究[J]. 实用妇科内分泌电子杂志, 2019, 6(14): 37.
[30]  杜正彩, 胡润华, 李瑞林, 等. 治疗阿尔茨海默病中药化学成分及机制的研究概况[J]. 中国实验方剂学杂志, 2024, 30(5): 236-245.
[31]  Molendijk, M.L., Spinhoven, P., Polak, M., Bus, B.A.A., Penninx, B.W.J.H. and Elzinga, B.M. (2013) Serum BDNF Concentrations as Peripheral Manifestations of Depression: Evidence from a Systematic Review and Meta-Analyses on 179 Associations (N = 9484). Molecular Psychiatry, 19, 791-800.
https://doi.org/10.1038/mp.2013.105

[32]  王雨露, 蔡朔, 李彬. 中药寡糖与多糖的抗抑郁作用研究进展[J]. 中国实验方剂学杂志, 2023, 29(24): 210-217.
[33]  林洁筠, 段阳, 龙淼青, 李超亚, 邓曼菲, 曾鹏. 柴胡疏肝散在抗抑郁治疗中的药效物质与作用机制研究进展[J]. 中国实验方剂学杂志, 2024, 30(10): 246-257.
[34]  刘丽, 刘青武, 冯雪, 李涛, 刘滨, 刘雅清, 杜欣珂, 李琦, 杨伟鹏. 重度抑郁症中的白质损伤及中医药治疗现状[J]. 中国实验方剂学杂志, 2023, 29(6): 237-245.
[35]  王慧敏, 秦雪梅, 刘晓节. 脑-肠交互视域下抑郁症与胃肠疾病共病的中西药调节及其机制研究进展[J]. 中草药, 2024, 55(1): 332-343.
[36]  Buckley, T.M. and Schatzberg, A.F. (2005) On the Interactions of the Hypothalamic-Pituitary-Adrenal (HPA) Axis and Sleep: Normal HPA Axis Activity and Circadian Rhythm, Exemplary Sleep Disorders. The Journal of Clinical Endocrinology & Metabolism, 90, 3106-3114.
https://doi.org/10.1210/jc.2004-1056

[37]  孙宁, 孙佳慧, 仲怀宇, 裴姗姗, 孙晶波. 中药镇静催眠作用机制的研究进展[J]. 中草药, 2023, 54(4): 1299-1310.
[38]  Garabadu, D., Shah, A., Ahmad, A., Joshi, V.B., Saxena, B., Palit, G., et al. (2010) Eugenol as an Anti-Stress Agent: Modulation of Hypothalamic-Pituitary-Adrenal Axis and Brain Monoaminergic Systems in a Rat Model of Stress. Stress, 14, 145-155.
https://doi.org/10.3109/10253890.2010.521602

[39]  Mason, B.L. and Pariante, C.M. (2006) The Effects of Antidepressants on the Hypothalamic-Pituitary-Adrenal Axis. Drug News & Perspectives, 19, 603-608.
[40]  劳梓滢, 蒋智锐, 张靖怡, 李彪平, 杨加顺, 唐玲. 小柴胡汤化学成分、药理作用研究进展及质量标志物(Q-Marker)预测[J]. 中草药, 2023, 54(19): 6520-6530.
[41]  Klein, S.D., Becker, S. and Wolf, U. (2012) Occurrence of Chai Hu (Bupleuri Radix) in Prescriptions of Chinese Herbal Medicine in Switzerland. Forschende Komplementärmedizin, 19, 242-246.
[42]  田磊, 栗俞程, 白明, 等. 栀子及其方剂配伍治疗抑郁症研究进展[J]. 中国实验方剂学杂志, 2023, 29(14): 239-247.
[43]  王林谭. 丹栀逍遥散对抑郁症临床疗效的影响[J]. 实用中西医结合临床, 2020, 20(11): 45-47.
[44]  刘玥婷, 王朝阳, 王瑜, 等. 耳甲电针对抑郁症模型大鼠前额叶皮质NLRP3、NF-κB、IL-1β蛋白表达的影响[J]. 中医杂志, 2020, 61(21): 1909-1914.
[45]  高策, 胡霞敏. 中药抗抑郁症的作用机制研究进展[J]. 天津中医药, 2023, 40(10): 1347-1355.
[46]  刘日群, 李字棋, 肖淑华, 等. 理气药抗抑郁作用及机制研究进展[J]. 中草药, 2024, 55(10): 3558-3568.
[47]  张瑜, 张红, 李宁, 等. 细辛化学成分和药理作用的研究进展及其质量标志物的预测分析[J]. 天然产物研究与开发, 2023, 35(10): 1794-1807.
[48]  邢楠楠, 屈怀东, 任伟超, 等. 五味子主要化学成分及现代药理作用研究进展[J]. 中国实验方剂学杂志, 2021, 27(15): 210-218.
[49]  董熠, 刘丽佳, 韩潞雯, 等. 香豆素类化学成分的药理作用及毒性机制研究进展[J]. 中草药, 2023, 54(16): 5462-5472.
[50]  周明园, 吕晓琳, 黄飞, 等. 针刺治疗抑郁症机制的近五年研究概述[J]. 环球中医药, 2023, 16(10): 2121-2126.
[51]  陶伟伟, 肖东, 吴浩然, 等. 基于药对探讨中药复方越鞠丸抗抑郁作用配伍规律[J]. 中国药理学通报, 2018, 34(9): 1314-1320.
[52]  刘慧丽. 基于数据挖掘探讨李冀教授辨治郁病的用药规律及经验总结[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2023.
[53]  Zhang, J., Liu, Y. and Xu, Y. (2020) Soothing Liver-Qi Stagnation Method for Cancer-Related Depression: A Protocol for Systematic Review and Meta-Analysis. Medicine, 99, e22797.
https://doi.org/10.1097/md.0000000000022797

[54]  关桂霞, 李时如, 田丰林, 等. 百合地黄汤联合盐酸曲唑酮治疗阴虚型抑郁障碍相关性失眠的临床疗效观察[J]. 中国实用医药, 2020, 15(8): 165-167.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133